Zobrazeno 1 - 10
of 5 860
pro vyhledávání: '"2019-nCOV"'
Autor:
Huang YC; From the Cell Science Systems Corporation, Deerfield Beach, Florida., Caldarone L; From the Cell Science Systems Corporation, Deerfield Beach, Florida., Sherman C; From the Cell Science Systems Corporation, Deerfield Beach, Florida., Deutsch R; From the Cell Science Systems Corporation, Deerfield Beach, Florida., Ahn J; Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center, Washington, D.C., Bellanti JA; Department of Pediatrics, Georgetown University School of Medicine, Washington, D.C.
Publikováno v:
Allergy and asthma proceedings [Allergy Asthma Proc] 2024 Nov 01; Vol. 45 (6), pp. 438-446.
Autor:
Murayama G; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan. Electronic address: gmuraya@juntendo.ac.jp., Kusaoi M; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan., Horiuchi Y; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan., Tabe Y; Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, 113-8421, Japan., Naito T; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, 113-8421, Japan., Ito S; Department of General Medicine, Juntendo University Faculty of Medicine, Tokyo, 113-8421, Japan; Medical Technology Innovation Centre, Juntendo University, Tokyo, 113-8421, Japan., Yamaji K; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan., Tamura N; Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, 113-8421, Japan.
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Oct; Vol. 30 (10), pp. 1021-1027. Date of Electronic Publication: 2024 Apr 01.
Autor:
Figueroa AL; Moderna, Cambridge, Massachusetts, USA., Azzi JR; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Eghtesad B; Cleveland Clinic, Cleveland, Ohio, USA., Priddy F; Moderna, Cambridge, Massachusetts, USA., Stolman D; Moderna, Cambridge, Massachusetts, USA., Siangphoe U; Moderna, Cambridge, Massachusetts, USA., Leony Lasso I; Moderna, Cambridge, Massachusetts, USA., de Windt E; Moderna, Cambridge, Massachusetts, USA., Girard B; Moderna, Cambridge, Massachusetts, USA., Zhou H; Moderna, Cambridge, Massachusetts, USA., Miller JM; Moderna, Cambridge, Massachusetts, USA., Das R; Moderna, Cambridge, Massachusetts, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Sep 23; Vol. 230 (3), pp. e591-e600.
Autor:
Zhang B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Fintzi J; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Chu E; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Janes HE; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kenny A; Department of Biostatistics, University of Washington, Seattle, WA, USA., Carone M; Department of Biostatistics, University of Washington, Seattle, WA, USA., Benkeser D; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, USA., van der Laan LWP; Department of Statistics, University of Washington, Seattle, WA, USA., Deng W; Moderna, Inc, Cambridge, MA, USA., Zhou H; Moderna, Inc, Cambridge, MA, USA., Wang X; Moderna, Inc, Cambridge, MA, USA., Lu Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Yu C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Borate B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Chen H; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Reeder I; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Carpp LN; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Houchens CR; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Martins K; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Jayashankar L; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Huynh C; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Fichtenbaum CJ; Division of Infectious Diseases, Department of Medicine, University of Cincinnati, Cincinnati, OH, USA., Kalams S; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Gay CL; Department of Medicine, Division of Infectious Diseases, UNC HIV Cure Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA., Andrasik MP; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA., Priddy F; Moderna, Inc, Cambridge, MA, USA., Das R; Moderna, Inc, Cambridge, MA, USA., Girard B; Moderna, Inc, Cambridge, MA, USA., El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA., Baden LR; Brigham and Women's Hospital, Boston, MA, USA., Jones T; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Donis RO; Biomedical Advanced Research and Development Authority, Washington, DC, USA., Koup RA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Biostatistics, University of Washington, Seattle, WA, USA., Follmann D; Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. dfollmann@niaid.nih.gov.
Publikováno v:
Nature communications [Nat Commun] 2024 Sep 11; Vol. 15 (1), pp. 7954. Date of Electronic Publication: 2024 Sep 11.
Autor:
Roozen GVT; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands; Department of Parasitology, LUCID, LUMC, Leiden, the Netherlands. Electronic address: g.v.t.roozen@lumc.nl., Granger A; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands., van Binnendijk RS; Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands., den Hartog G; Department of Immune Surveillance, National Institute for Public Health and the Environment (RIVM), Utrecht, the Netherlands; Laboratory of Medical Immunology, Radboudumc, Nijmegen, the Netherlands., Roestenberg M; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands; Department of Parasitology, LUCID, LUMC, Leiden, the Netherlands., Visser LG; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands., Roukens AHE; Department of Infectious Diseases, Leiden University - Center for Infectious Diseases (LUCID), Leiden University Medical Center (LUMC), Leiden, the Netherlands.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126093. Date of Electronic Publication: 2024 Jun 29.
Autor:
Kirk B; Aetion, Inc., 5 Pennsylvania Plaza, New York, NY 10001, USA., Bush C; Aetion, Inc., 5 Pennsylvania Plaza, New York, NY 10001, USA., Toyip A; Aetion, Inc., 5 Pennsylvania Plaza, New York, NY 10001, USA., Mues KE; Aetion, Inc., 5 Pennsylvania Plaza, New York, NY 10001, USA., Beck E; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA. Electronic address: Ekkehard.Beck@modernatx.com., Li L; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., St Laurent S; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Georgieva M; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Marks MA; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Sun T; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Esposito DB; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Martin D; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA., Van de Velde N; Moderna, Inc., 325 Binney Street, Cambridge, MA 02142, USA.
Publikováno v:
Vaccine [Vaccine] 2024 Nov 14; Vol. 42 (25), pp. 126113. Date of Electronic Publication: 2024 Jul 18.
Autor:
Morciano C; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Massari M; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Cutillo M; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Belleudi V; Department of Epidemiology ASL Roma 1, Lazio Regional Health Service, Rome, Italy., Trifirò G; Department of Diagnostics and Public Health, University of Verona, Verona, Italy., Mores N; Institute of Pharmacology, Pharmacovigilance, Policlinico Universitario A. Gemelli, Catholic University of Sacred Heart, Rome, Italy., Sapigni E; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy., Puccini A; Hospital Assistance Service, General Directorate for Personal Care, Health and Welfare, Emilia-Romagna Region, Bologna, Italy., Zanoni G; Immunology Unit, University Hospital, Verona, Italy., Zorzi M; Cancer Registry of Veneto, Azienda Zero, Padua, Italy., Monaco G; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy., Leoni O; Department of Health of Lombardy Region, Epidemiology Observatory, Milan, Italy., Del Zotto S; Regional Health Authority, Friuli Venezia Giulia Region, Udine, Italy., Samez S; Regional Pharmacovigilance Centre, Trieste, Italy., Mayer F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Marano G; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Menniti Ippolito F; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Da Cas R; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Traversa G; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy., Spila Alegiani S; National Centre for Drug Research and Evaluation, Italian National Institute of Health, Rome, Italy. stefania.spila@iss.it.
Publikováno v:
Drug safety [Drug Saf] 2024 Nov; Vol. 47 (11), pp. 1157-1169. Date of Electronic Publication: 2024 Jul 27.
Autor:
Dimitrov Y; Department of nephrology & dialysis, Centre Hospitalier de Haguenau, Haguenau, France.; Renal Research Division, AURAL, 5 rue Henri Bergson, Strasbourg, 67087, France., Krummel T; Department of nephrology, dialysis & transplantation, Centre Hospitalo-Universitaire de Strasbourg, Strasbourg, France., Chantrel F; Renal Research Division, AURAL, 5 rue Henri Bergson, Strasbourg, 67087, France.; Department of nephrology & dialysis, Groupe Hospitalier de Mulhouse-Sud Alsace, Mulhouse, France., Heibel F; Renal Research Division, AURAL, 5 rue Henri Bergson, Strasbourg, 67087, France.; Department of nephrology, dialysis & transplantation, Centre Hospitalo-Universitaire de Strasbourg, Strasbourg, France., Kribs M; Department of nephrology & dialysis, Centre Hospitalier de Haguenau, Haguenau, France.; Renal Research Division, AURAL, 5 rue Henri Bergson, Strasbourg, 67087, France., Hannedouche T; Renal Research Division, AURAL, 5 rue Henri Bergson, Strasbourg, 67087, France. thannedouche@unistra.fr.
Publikováno v:
BMC nephrology [BMC Nephrol] 2024 Oct 31; Vol. 25 (1), pp. 391. Date of Electronic Publication: 2024 Oct 31.
Autor:
Liu S; Department of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, the Netherlands. Electronic address: s.liu@umcg.nl., van Dijk LLA; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., den Hartog Y; Department of Internal Medicine, Nephrology and Transplantation, Erasmus MC Transplant Institute, Erasmus University Medical Center, Rotterdam, the Netherlands., Hoek R; Department of Pulmonary Medicine, University Medical Center Rotterdam, Rotterdam, the Netherlands., Verschuuren E; Department of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Geurtsvankessel CH; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., de Vries RD; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Van Baarle D; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands. Electronic address: d.van.baarle@umcg.nl., Buter CVL; Department of Medical Microbiology, University of Groningen, University Medical Center Groningen, the Netherlands.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 24; Vol. 42 (24), pp. 126250. Date of Electronic Publication: 2024 Sep 02.
Autor:
Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA., Ayoub HH; Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar., Coyle P; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Hamad Medical Corporation, Doha, Qatar.; Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, UK., Tang P; Department of Pathology, Sidra Medicine, Doha, Qatar., Hasan MR; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada., Yassine HM; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al Thani AA; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al-Kanaani Z; Hamad Medical Corporation, Doha, Qatar., Al-Kuwari E; Hamad Medical Corporation, Doha, Qatar., Jeremijenko A; Hamad Medical Corporation, Doha, Qatar., Kaleeckal AH; Hamad Medical Corporation, Doha, Qatar., Latif AN; Hamad Medical Corporation, Doha, Qatar., Shaik RM; Hamad Medical Corporation, Doha, Qatar., Abdul-Rahim HF; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar., Nasrallah GK; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; Biomedical Research Center, QU Health, Qatar University, Doha, Qatar., Al-Kuwari MG; Primary Health Care Corporation, Doha, Qatar., Butt AA; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.; Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Weill Cornell Medicine, Cornell University, New York, New York, USA., Al-Romaihi HE; Ministry of Public Health, Doha, Qatar., Al-Thani MH; Ministry of Public Health, Doha, Qatar., Al-Khal A; Hamad Medical Corporation, Doha, Qatar., Bertollini R; Ministry of Public Health, Doha, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, New York, USA.; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.; College of Health and Life Sciences, Hamad bin Khalifa University, Doha, Qatar.
Publikováno v:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Oct; Vol. 18 (10), pp. e13357.